Venous angioplasty in multiple sclerosis: Neurological outcome at two years in a cohort of relapsing-remitting patients

Functional Neurology

Volumn 27, Issue 1, 2012, Pages 55-59

  Salvi, Fabrizio ^a   Bartolomei, Ilaria ^a   Buccellato, Elena ^a   Galeotti, Roberto ^b   Zamboni, Paolo ^c  

^a BELLARIA HOSPITAL   (Italy)

^b S ANNA HOSPITAL   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Multiple sclerosis; Neurological outcome; Venous angioplasty

Indexed keywords

BETA1A INTERFERON; FONDAPARINUX; GLATIRAMER; HEPARIN; INTERFERON BETA SERINE; METHYLPREDNISOLONE; MITOXANTRONE;

ADULT; ARTICLE; AZYGOS VEIN; BLEEDING; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DEATH; DRUG MEGADOSE; ENDOVASCULAR SURGERY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERNAL JUGULAR VEIN; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RELAPSE; RISK ASSESSMENT; RISK REDUCTION; SHOCK; STENOSIS; THROMBOSIS PREVENTION; TREATMENT DURATION; VENOUS RESTENOSIS;

ADULT; ANGIOPLASTY; AZYGOS VEIN; CEREBROVASCULAR DISORDERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; JUGULAR VEINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; TREATMENT OUTCOME; VENOUS INSUFFICIENCY; YOUNG ADULT;

EID: 84862612133     PISSN: 03935264     EISSN: 19713274     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sadovnick AD, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993;20:17-29
2. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285
3. Haacke EM. Chronic cerebral spinal venous insufficiency in multiple sclerosis. Expert Rev Neurother 2011;11:5-9
4. Filippi M, Rocca MA, Barkhof F, et al. Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective. AJNR Am J Neuroradiol 2011;32:424-427
5. Zamboni P, Galeotti R, Menegatti E, et al. Chronic cere-brospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009;80:392-399
6. Simka M, Kostecki J, Zaniewski M, Majewski E, Hartel M. Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in the patients with multiple sclerosis. Int Angiol 2010; 29:109-114
7. Al-Omari MH, Rousan LA. Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis. Int Angiol 2010;29:115-120
8. Zivadinov R, Marr K, Cutter G et al. Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology 2011;12:138-144
9. Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 2010;68:173-183
10. Sundstrom P, Wåhlin A, Ambarki K, Birgander R, Eklund A, Malm J. Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol 2010;68:255-259
11. Wattjes MP, van Oosten BW, de Graaf WL et al. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flowquantification study. J Neurol Neurosurg Psychiatry 2011;82:429-435
12. Mayer CA, Pfeilschifter W, Lorenz MW et al. The perfect crime? CSSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry 2011;82:436-440
13. Khan O, Filippi M, Freedman FS et al. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol 2010;67:286-290
14. Van Rensburg SJ, van Toorn R. The controversy of CSSVI and iron in multiple sclerosis: is ferritin the key? Neurology 2010;75: 1581-1582
15. Khan O, Tselis A. Chronic cerebrospinal venous insufficiency and multiple sclerosis: science or science fiction? J Neurol Neurosurg Psychiatry 2011;82:355
16. Zamboni P, Galeotti R, Menegatti E et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg 2009;50:1348-1358. Erratum in: J Vasc Surg 2010;51:1079
17. Zamboni P, Galeotti R, Weinstock-Guttman B, Kennedy C, Salvi F, Zivadinov R. Venous angioplasty in patients with multiple sclerosis. Results of a pilot study. Eur J Vasc Endovasc Surg 2012;43:116-122
18. Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revision to the "Mc Donald criteria". Ann Neurol 2005;58:840-846
19. Zamboni P, Menegatti E, Galeotti R, et al. The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J Neurol Sci 2009;282:21-27
20. Plosker GL. Interferon-1b: a review of its use in multiple sclerosis. CNS Drugs 2011;25:67-88
21. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13: 227-231.
22. Louis TA, Lavori PW, Bailar III JC, Polansky M. Crossover and self-controlled designs in clinical research. In: Bailar III JC, Mosteller F eds Medical Uses of Statistics. Waltham MA, USA; NEJM Books 1986:67-90
23. Inusah S, Sormani MP, Cofield SS et al. Assessing changes in relapse rates in multiple sclerosis. Mult Scler 2010;16:1414-1421
24. Amato MP, Grimaud J, Achiti I et al. European validation of a standardized clinical description of multiple sclerosis. J Neurol 2004;251:1472-1480
25. Young, PJ, Lederer C, Eder K et al. Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis. Neurology 2006;67:804-808
26. Zamboni P, Menegatti E, Weinstock-Guttman B et al. Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross sectional preliminary report. BMC Med 2011;9:22
27. D'haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J. Vascular aspects of multiple sclerosis. Lancet Neurol. 2011;10:657-666
28. Simka M. Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis. Curr Neurovasc Res 2009;6:132-139
29. Siskin GP, Haskal ZJ, McLennan G et al. Development of a research agenda for evaluation of interventional therapies for chronic cerebrospinal venous insufficiency: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 2011;22:587-593.